Skip to the page

Data / Form D filings / Onspira Therapeutics, Inc.

Onspira Therapeutics, Inc.: Form D filings

Onspira Therapeutics, Inc., a pharmaceuticals company in Wayne, PA, filed 3 Form D notices with the SEC between 2017 and 2019. The latest, on June 25, 2019, reports $1.9 million sold of a $1.9 million offering to 30 investors.

Find out what Onspira Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
640 LEE ROAD, SUITE 117, Wayne, PA, 19087
Phone
(484) 318-2988
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2017
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1709961

The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 25, 2019Amendment$1,925,000$1,925,000$030Jun 16, 2017sec.gov
Oct 29, 2018Amendment$1,500,000$1,500,000$029Jun 16, 2017sec.gov
Jun 21, 2017New notice$1,000,000$1,000,000$027Jun 16, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roy LevittExecutive Officer, Director
Stephen TullmanExecutive Officer, Director
Paul BaroneExecutive Officer, Director
Brian LortieExecutive Officer, Director
Douglas GesslExecutive Officer

Other pharmaceuticals companies in Pennsylvania that filed recently

Every Form D from the week of Jun 24, 2019 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Onspira Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.